These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9751930)

  • 41. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study.
    Petersen W; Heilmann C; Garne S
    Acta Paediatr Scand; 1987 Jan; 76(1):66-9. PubMed ID: 3551493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human postprandial gastric emptying of 1-3-millimeter spheres.
    Meyer JH; Elashoff J; Porter-Fink V; Dressman J; Amidon GL
    Gastroenterology; 1988 Jun; 94(6):1315-25. PubMed ID: 3360258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High dose pancreatic enzymes in cystic fibrosis.
    Robinson PJ; Sly PD
    Arch Dis Child; 1990 Mar; 65(3):311-2. PubMed ID: 2334211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects.
    Youngberg CA; Berardi RR; Howatt WF; Hyneck ML; Amidon GL; Meyer JH; Dressman JB
    Dig Dis Sci; 1987 May; 32(5):472-80. PubMed ID: 3646103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man.
    Fuessl HS; Carolan G; Williams G; Bloom SR
    Digestion; 1987; 36(2):101-7. PubMed ID: 2883059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis.
    Mukhopadhyay S; Staddon GE; Eastman C; Palmer M; Davies ER; Carswell F
    Respir Med; 1994 Mar; 88(3):203-11. PubMed ID: 8209069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of liquid versus solid diet on colonic transit in humans. Evaluation by standard colonic transit scintigraphy.
    Kaufman PN; Richter JE; Chilton HM; Kerr RM; Cowan RC; Gelfand DW; Ott DJ
    Gastroenterology; 1990 Jan; 98(1):73-81. PubMed ID: 2293600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
    N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut hormones and gastrointestinal motility in children with cystic fibrosis.
    Murphy MS; Brunetto AL; Pearson AD; Ghatei MA; Nelson R; Eastham EJ; Bloom SR; Green AA
    Dig Dis Sci; 1992 Feb; 37(2):187-92. PubMed ID: 1735334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB
    Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simplified method for the measurement of segmental colonic transit time.
    Notghi A; Hutchinson R; Kumar D; Smith NB; Harding LK
    Gut; 1994 Jul; 35(7):976-81. PubMed ID: 8063227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
    Kraisinger M; Hochhaus G; Stecenko A; Bowser E; Hendeles L
    J Clin Pharmacol; 1994 Feb; 34(2):158-66. PubMed ID: 8163716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy.
    Maurer AH; Krevsky B; Knight LC; Brown K
    J Nucl Med; 1996 May; 37(5):818-22. PubMed ID: 8965152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results.
    Becker W; Schomann E; Fischbach W; Börner W; Gruner KR
    Nucl Med Commun; 1988 Jun; 9(6):435-47. PubMed ID: 3137513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stable isotope studies of pancreatic enzyme release in vivo.
    Seal S; McClean P; Walters M; Wolfe SP; Harding M; Coward W; Littlewood JM
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S37-8. PubMed ID: 8869181
    [No Abstract]   [Full Text] [Related]  

  • 57. Scintigraphic measurement of regional gut transit in idiopathic constipation.
    Stivland T; Camilleri M; Vassallo M; Proano M; Rath D; Brown M; Thomforde G; Pemberton J; Phillips S
    Gastroenterology; 1991 Jul; 101(1):107-15. PubMed ID: 2044899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small intestinal permeability and orocaecal transit time in cystic fibrosis.
    Dalzell AM; Freestone NS; Billington D; Heaf DP
    Arch Dis Child; 1990 Jun; 65(6):585-8. PubMed ID: 2116115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radionuclide transit in patients with colon interposition.
    Isolauri J; Koskinen MO; Markkula H
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):521-5. PubMed ID: 3657255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.